Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1978 Jul;62(7):428–439. doi: 10.1136/bjo.62.7.428

Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.

B R Jones, J Anderson, H Fuglsang
PMCID: PMC1043252  PMID: 678494

Abstract

Diethylcarbamazine was given as eye drops in varying concentrations in a half-log dilution series from 1.0 to 0.0001% to patients with ocular onchocerciasis. Migration of microfilariae into the cornea, followed by their straightening and disintegration, was observed with delivery rates as low as 0.1 microgram/hour. Dose-related adverse inflammatory reactions, including the development of globular limbal infiltrates with itching and redness, were seen with delivery rates as low as 0.6 microgram/hour, but substantial inflammatory reactions, including severe vasculitis, were seen only with delivery rates of or above 1.0 microgram/hour. This suggests that it should be possible to achieve beneficial clearing of the microfilarial load, without adverse reactions, by continuous non-pulsed delivery of the drug. Technology exists for such delivery, either directly into the eye or systemically by a transdermal system that could give 3 to 7 days' treatment from each application. The observations reported suggest that after preliminary clearing of the microfilarial load by carefully controlled delivery of DEC it may be possible to maintain therapy by less strictly controlled delivery in DEC-medicated salt, or to use treatment with suramin, without incurring substantial adverse reactions, such as a deterioration in vision in cases in which the optic nerve is already compromised. Continuous non-pulsed DEC delivery systems could have a place in the management of onchocercal sclerosing keratitis. The unique opportunities for using the ocular model to define the requirements for beneficial non-damaging therapy with DEC should be explored in further field trials.

Full text

PDF
428

Images in this article

433Image
on p.433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J., Fuglsang H. Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin. Br J Ophthalmol. 1978 Jul;62(7):450–457. doi: 10.1136/bjo.62.7.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson J., Fuglsang H. Topical diethylcarbamazine in ocular onchocerciasis. Trans R Soc Trop Med Hyg. 1973;67(5):710–717. doi: 10.1016/0035-9203(73)90042-4. [DOI] [PubMed] [Google Scholar]
  3. Anderson J., Fuglsang H., de C Marshall T. F. Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol. 1976 Sep;27(3):263–278. [PubMed] [Google Scholar]
  4. Anderson J., Fuglsang H., de C Marshall T. F. Effects of suramin on ocular onchocerciasis. Tropenmed Parasitol. 1976 Sep;27(3):279–296. [PubMed] [Google Scholar]
  5. Aviel E., David R. Topical diethylcarbamazine in ocular onchocerciasis. Isr J Med Sci. 1972 Aug-Sep;8(8):1166–1168. [PubMed] [Google Scholar]
  6. Ben-Sira I., Aviel E., Lazar M., Liebermann T. W., Leopold I. H. Topical hetrazan in the treatment of ocular onchocerciasis. Am J Ophthalmol. 1970 Nov;70(5):741–743. doi: 10.1016/0002-9394(70)90493-9. [DOI] [PubMed] [Google Scholar]
  7. Bryceson A. D., Warrell D. A., Pope H. M. Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine. Br Med J. 1977 Mar 19;1(6063):742–744. doi: 10.1136/bmj.1.6063.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis A., Bailey D. R. The effect of salt medicated with diethylcarbamazine in bancroftian filariasis. Bull World Health Organ. 1969;41(2):195–208. [PMC free article] [PubMed] [Google Scholar]
  9. Duke B. O. Letter: Route of entry of Onchocerca volvulus microfilariae into the eye. Trans R Soc Trop Med Hyg. 1976;70(1):90–90. doi: 10.1016/0035-9203(76)90021-3. [DOI] [PubMed] [Google Scholar]
  10. Duke B. O., Vincelette J., Moore P. J. Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed Parasitol. 1976 Jun;27(2):123–132. [PubMed] [Google Scholar]
  11. Fuglsang H., Anderson J. Effects of a single dose of metrifonate on the forest strain of Onchocerca volvulus in Cameroon. Tropenmed Parasitol. 1977 Dec;28(4):439–446. [PubMed] [Google Scholar]
  12. Fuglsang H., Anderson J. Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine. Trans R Soc Trop Med Hyg. 1974;68(1):72–73. doi: 10.1016/0035-9203(74)90259-4. [DOI] [PubMed] [Google Scholar]
  13. HAWKING F., SEWELL P., THURSTON J. P. The mode of action of hetrazan on filarial worms. Br J Pharmacol Chemother. 1950 Jun;5(2):217–238. doi: 10.1111/j.1476-5381.1950.tb01010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hawking F., Marques R. J. Control of Bancroftian filariasis by cooking salt medicated with diethylcarbamazine. Bull World Health Organ. 1967;37(3):405–414. [PMC free article] [PubMed] [Google Scholar]
  15. Jones B. R., Anderson J., Fuglsang H. Evaluation of microfilaricidal effects in the cornea from topically applied drugs in ocular onchocerciasis: Trials with levamisole and mebendazole. Br J Ophthalmol. 1978 Jul;62(7):440–444. doi: 10.1136/bjo.62.7.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lazar M., Lieberman T. W., Furman M., Leopold I. H. Ocular penetration of hetrazan in rabbits. Am J Ophthalmol. 1968 Aug;66(2):215–220. doi: 10.1016/0002-9394(68)92066-7. [DOI] [PubMed] [Google Scholar]
  17. Lazar M., Lieberman T. W., Leopold I. H. Topical diethylcarbamazine in the treatment of ocular onchocerciasis. Am J Trop Med Hyg. 1970 Mar;19(2):232–233. doi: 10.4269/ajtmh.1970.19.232. [DOI] [PubMed] [Google Scholar]
  18. Oomen A. P. Fatalities after treatment of onchocerciasis with diethylcarbamazine. Trans R Soc Trop Med Hyg. 1969;63(4):548–548. doi: 10.1016/0035-9203(69)90055-8. [DOI] [PubMed] [Google Scholar]
  19. SCHOFIELD F. D., ROWLEY R. E. The effect of prednisone on persistent microfilaremia during treatment with diethylcarbamazine. Am J Trop Med Hyg. 1961 Nov;10:849–854. doi: 10.4269/ajtmh.1961.10.849. [DOI] [PubMed] [Google Scholar]
  20. Sen A. B., Chandra R., Katiyar J. C., Chandra S. Diethylcarbamazine medicated salt in the chemotherapeutic control of filariasis due to Wuchereria bancrofti in an open community. Indian J Med Res. 1974 Aug;62(8):1181–1189. [PubMed] [Google Scholar]
  21. Williams H. P., Falcon M. G., Jones B. R. Corticosteroids in the management of herpetic eye disease. Trans Ophthalmol Soc U K. 1977 Jul;97(2):341–344. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES